Compare Moderna, Inc. (MRNA) vs Oklo Inc (OKLO) Price & Performance

Moderna, Inc.Trade

Oklo IncTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Oklo Inc — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Oklo Inc trades at $46.78 (market cap $7.22B). The key difference: Moderna, Inc. is far larger — about 3.3× Oklo Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.

	MRNA	OKLO
Market Cap	$23.60B	$7.22B
Sector	Health	Technology
52-Week High	$81.80	$174.14
52-Week Low	$22.36	$41.11
Enterprise Value	$19.70B	$5.02B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MRNA

ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026.24/7 Wall Street · 13 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

OKLO

US DOE formalizes Nuclear Fuel Cycle Consortium to boost domestic nuclear fuel resilience.ETF Trends · 1 day agoBullish View details →

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

About Oklo Inc

Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.